| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | +26.4% |
| R&D Expense | $50.6M | +28.5% |
| SG&A Expense | $25.0M | +3.6% |
| Operating Income | -$72.9M | -18.8% |
| Interest Expense | $2.1M | -78.6% |
| Pre-tax Income | -$73.8M | -3.7% |
| Income Tax | $0 | — |
| Net Income | -$73.8M | -3.7% |
| EPS (Basic) | -$0.38 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.9M | +252.6% |
| Current Assets | $92.9M | -12.2% |
| Total Assets | $95.0M | -12.5% |
| Current Liabilities | $21.7M | +16.5% |
| Long-term Debt | $24.5M | — |
| Total Liabilities | $47.7M | +125.8% |
| Stockholders' Equity | $47.4M | -45.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.7M | -19.0% |
| Capital Expenditures | $196K | +0.0% |
| Investing Cash Flow | $66.2M | — |
| Financing Cash Flow | $51.8M | +652.1% |
| Free Cash Flow | -$63.9M | -18.9% |
| +7.3% |
| EPS (Diluted) | -$0.38 | +7.3% |